Complement in clinical medicine: Clinical trials, case reports and therapy monitoring
Open Access
- 1 September 2017
- journal article
- review article
- Published by Elsevier in Molecular Immunology
- Vol. 89, 10-21
- https://doi.org/10.1016/j.molimm.2017.05.013
Abstract
No abstract availableKeywords
This publication has 69 references indexed in Scilit:
- Anti-C1q Autoantibodies, Novel Tests, and Clinical ConsequencesFrontiers in Immunology, 2013
- Complement Diagnostics: Concepts, Indications, and Practical GuidelinesClinical and Developmental Immunology, 2012
- The complotype: dictating risk for inflammation and infectionTrends in Immunology, 2012
- A prevalent C3 mutation in aHUS patients causes a direct C3 convertase gain of functionBlood, 2012
- Inhibiting Alternative Pathway Complement Activation by Targeting the Factor D ExositeJournal of Biological Chemistry, 2012
- Common polymorphisms in C3, factor B, and factor H collaborate to determine systemic complement activity and disease riskProceedings of the National Academy of Sciences, 2011
- Atypical Hemolytic Uremic Syndrome Associated with Mutations in Complement Regulator GenesSeminars in Thrombosis and Hemostasis, 2010
- Complement: a key system for immune surveillance and homeostasisNature Immunology, 2010
- Erythrocyte C3d and C4d for monitoring disease activity in systemic lupus erythematosusArthritis & Rheumatism, 2010
- Complement-targeted therapeuticsNature Biotechnology, 2007